Epilepsia Open (Dec 2024)

The implications of frailty in older adults with epilepsy

  • Syeda Amrah Hashmi,
  • Seerat Sachdeva,
  • Udeept Sindhu,
  • Carolyn Tsai,
  • Kalyanchakradhar Bonda,
  • Mark Keezer,
  • Ifrah Zawar,
  • Vineet Punia

DOI
https://doi.org/10.1002/epi4.13046
Journal volume & issue
Vol. 9, no. 6
pp. 2128 – 2143

Abstract

Read online

Abstract Older adults constitute a large proportion of people with epilepsy (PWE) due to the changing demographics worldwide and epilepsy's natural history. Aging‐related pathophysiological changes lower the tolerance and increase our vulnerability to stressors, which manifests as frailty. Frailty is closely associated with adverse health outcomes. This narrative review examines the interplay between frailty and epilepsy, especially in older adults, emphasizing its clinical implications, including its role in managing PWE. Mechanistically, frailty develops through complex interactions among molecular and cellular damage, including genomic instability, mitochondrial dysfunction, and hormonal changes. These contribute to systemic muscle mass, bone density, and organ function decline. The concept of frailty has evolved from a primarily physical syndrome to include social, psychological, and cognitive dimensions. The “phenotypic frailty” model, which focuses on physical performance, and the “deficit accumulation” model, which quantifies health deficits, provide frameworks for understanding and assessing frailty. PWE are potentially more prone to developing frailty due to a higher prevalence of risk factors predisposing to frailty. These include, but are not limited to, polypharmacy, higher comorbidity, low exercise level, social isolation, low vitamin D, and osteoporosis. We lack commercial biomarkers to measure frailty but can diagnose it using self‐ or healthcare provider‐administered frailty scales. Recent attempts to develop a PWE‐specific frailty scale are promising. Unlike chronological age, frailty is reversible, so its management using multidisciplinary care teams should be strongly considered. Frailty can affect antiseizure medication (ASM) tolerance secondary to its impact on pharmacokinetics and pharmacodynamics. While frailty's effect on seizure control efficacy of ASM is poorly understood, its undoubted association with overall poor outcomes, including epilepsy surgery, behooves us to consider its presence and implication while treating older PWE. Incorporation of frailty measures in future research is essential to improve our understanding of frailty's role in PWE health. Plain Language Summary Frailty is the declining state of the human body. People with epilepsy are more prone to it. It should be factored into their management.

Keywords